Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felicitas Thol

Showing results (91-100 of 126) with videos related to

Pageof 13
Sort By:
Annals of Hematology|April 27, 2021
Genome-wide DNA methylation analysis pre- and post-lenalidomide treatment in patients with myelodysplastic syndrome with isolated deletion (5q)Anna Hecht, Julia A Meyer, Johann-Christoph Jann, et al.
Blood|June 17, 2022
Enasidenib vs conventional care in older patients with late-stage mutant-IDH2 relapsed/refractory AML: a randomized phase 3 trialStéphane de Botton, Pau Montesinos, Andre C Schuh, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 9, 2017
Impact of Molecular Genetics on Outcome in Myelofibrosis Patients after Allogeneic Stem Cell TransplantationNicolaus Kröger, Victoria Panagiota, Anita Badbaran, et al.
Annals of Hematology|December 28, 2022
Molecular response patterns in relapsed/refractory AML patients treated with selinexor and chemotherapyPiroska Klement, Walter Fiedler, Razif Gabdoulline, et al.
The New England Journal of Medicine|June 9, 2016
Genomic Classification and Prognosis in Acute Myeloid LeukemiaElli Papaemmanuil, Moritz Gerstung, Lars Bullinger, et al.
American Journal of Hematology|February 15, 2024
Splenic irradiation for myelofibrosis prior to hematopoietic cell transplantation: A global collaborative analysisNico Gagelmann, Gabriela S Hobbs, Edoardo Campodonico, et al.
Blood|January 6, 2019
Genomic landscape and clonal evolution of acute myeloid leukemia with t(8;21): an international study on 331 patientsFriederike Christen, Kaja Hoyer, Kenichi Yoshida, et al.
Blood|September 27, 2019
Measurable residual disease monitoring in acute myeloid leukemia with t(8;21)(q22;q22.1): results from the AML Study GroupFrank G Rücker, Mridul Agrawal, Andrea Corbacioglu, et al.
Hemasphere|August 5, 2021
Adjunctive Volasertib in Patients With Acute Myeloid Leukemia not Eligible for Standard Induction Therapy: A Randomized, Phase 3 TrialHartmut Döhner, Argiris Symeonidis, Dries Deeren, et al.
Blood Advances|November 19, 2024
Role of molecular alterations in transplantation decisions for patients with primary myelofibrosisDamien Luque Paz, Nico Gagelmann, Lina Benajiba, et al.
Pageof 13

Showing results (91-100 of 126) with videos related to

Sort By:
Pageof 13
Annals of Hematology|April 27, 2021
Genome-wide DNA methylation analysis pre- and post-lenalidomide treatment in patients with myelodysplastic syndrome with isolated deletion (5q)Anna Hecht, Julia A Meyer, Johann-Christoph Jann, et al.
Blood|June 17, 2022
Enasidenib vs conventional care in older patients with late-stage mutant-IDH2 relapsed/refractory AML: a randomized phase 3 trialStéphane de Botton, Pau Montesinos, Andre C Schuh, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 9, 2017
Impact of Molecular Genetics on Outcome in Myelofibrosis Patients after Allogeneic Stem Cell TransplantationNicolaus Kröger, Victoria Panagiota, Anita Badbaran, et al.
Annals of Hematology|December 28, 2022
Molecular response patterns in relapsed/refractory AML patients treated with selinexor and chemotherapyPiroska Klement, Walter Fiedler, Razif Gabdoulline, et al.
The New England Journal of Medicine|June 9, 2016
Genomic Classification and Prognosis in Acute Myeloid LeukemiaElli Papaemmanuil, Moritz Gerstung, Lars Bullinger, et al.
American Journal of Hematology|February 15, 2024
Splenic irradiation for myelofibrosis prior to hematopoietic cell transplantation: A global collaborative analysisNico Gagelmann, Gabriela S Hobbs, Edoardo Campodonico, et al.
Blood|January 6, 2019
Genomic landscape and clonal evolution of acute myeloid leukemia with t(8;21): an international study on 331 patientsFriederike Christen, Kaja Hoyer, Kenichi Yoshida, et al.
Blood|September 27, 2019
Measurable residual disease monitoring in acute myeloid leukemia with t(8;21)(q22;q22.1): results from the AML Study GroupFrank G Rücker, Mridul Agrawal, Andrea Corbacioglu, et al.
Hemasphere|August 5, 2021
Adjunctive Volasertib in Patients With Acute Myeloid Leukemia not Eligible for Standard Induction Therapy: A Randomized, Phase 3 TrialHartmut Döhner, Argiris Symeonidis, Dries Deeren, et al.
Blood Advances|November 19, 2024
Role of molecular alterations in transplantation decisions for patients with primary myelofibrosisDamien Luque Paz, Nico Gagelmann, Lina Benajiba, et al.
Pageof 13